Trevena (TRVN)
(Delayed Data from NSDQ)
$4.49 USD
+4.28 (2,088.06%)
Updated Aug 13, 2024 03:44 PM ET
After-Market: $4.37 -0.12 (-2.67%) 5:56 PM ET
3-Hold of 5 3
F Value A Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 28% (71 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.28 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -0.57 | 0.12 | 54.84 |
Next Quarter Estimate | -0.28 | 7.81 | 63.00 |
Next Year Estimate | -0.79 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 59.18 | 17.10 | 15.67 |
Next Year | 38.76 | 9.40 | 11.34 |
Last 5 Years | NA | 0.70 | 8.10 |
Next 5 Years | NA | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | NA | 1.91 |
Price/Cash Flow (MRFY) | NA | 15.24 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -87.29% |
Return on Equity (TTM) | -1,018.15% | -47.30% |
Debt to Equity (MRQ) | -1.66 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.